Retire early on these 3 stocks

These three growth and income blue-chips could form the solid core your retirement portfolio, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you dream of enjoying your retirement, you had better get saving for it. Stocks and shares offer an unbeatable combination of share price growth and a rising dividend income as well. The following three companies could form the basis of a balanced retirement income portfolio, and help you beat today’s rock bottom savings rates.

BP

The oil sector has been volatile lately but the picture looks a little brighter now that oil has stabilised at around $50-$55 a barrel. This is a big improvement on $27, a low hit in January last year. Oil majors like BP (LSE: BP) have worked hard to survive the current era of cheap crude, selling off non-core assets, slashing headcount and capex, and dropping less productive exploration opportunities. The medicine has worked, the patient is largely restored.

BP still faces challenges. Crude could fall again. Recent OPEC and non-OPEC production cuts have been applied with greater rigour than sceptics anticipated but US shale drillers are plugging the shortfall. The days of $100 oil may never return. BP is still making money at this level, with a $400m profit for the final three months of 2016, if below analysts’s expectations of $567m. However, income seekers will be beguiled by its turbo-charged 6.57% yield, which is more than 26 times base rate. Let the dividends roll…

GlaxoSmithKline

Pharmaceuticals maker GlaxoSmithKline (LSE: GSK) is another FTSE 100 stalwart that has been through a volatile time. As with BP, the future is looking brighter, its share price up 20% over the past year, and almost 10% in the past month. This recent spike may be down to encouraging results from clinical tests on asthma sufferers of its Relvar Ellipta inhaler treatment, which would mark another step forward in the company’s drive to replenish its drugs pipeline.

Glaxo has also been upbeat about new HIV drug tests and is awaiting regulatory decisions on four major products this year – Shingrix, Closed Triple, Benlysta SC and sirukumab, with the results directly impacting on the share price. Glaxo currently offers dividend income of 4.8%, with the prospect of steady growth in future. The future looks promising, with forecast earnings per share growth of 9% this year and 3% in 2018. Possibly the ultimate retirement stock.

Unilever

Sorry, scrap that. Household goods giant Unilever (LSE: ULVR) is possibly the ultimate retirement stock. It has seen steady share price growth year after year, including another 25% in the last 12 months. Its current yield of 2.82% is better than it looks because management’s policy has always been very progressive, it’s just been difficult for the yield to keep up with the surging share price.

I was delighted to see the $143bn takeover offer from Kraft Heinz rebuffed. This well-run company has plenty to offer shareholders over the long term without takeover disruption. The failed attempt may have a positive side, forcing the company to bolster shareholder returns, and target an increase in its relatively low 15% operating margins. Unilever doesn’t divide investors, unlike its best-known product Marmite. They either love it, or they love it.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »